The Role of Vpr and Vpx in Lentivirus Replication
Vpr和Vpx在慢病毒复制中的作用
基本信息
- 批准号:9296016
- 负责人:
- 金额:$ 42.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-15 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAmino Acid SequenceAmino AcidsAntiviral AgentsBindingBiochemicalBiological AssayCell CycleCell NucleusCell physiologyCellsCo-ImmunoprecipitationsCollaborationsCoupledDNADendritic CellsDropsEffectivenessEngineeringEnzymesExonucleaseFlow CytometryFundingGoalsHIVHIV-1HIV-2HumanImmune responseImmune systemInfectionInnate Immune ResponseInnate Immune SystemIntegration Host FactorsLaboratoriesLeukocytesLightLocationLymphoidMass Spectrum AnalysisMedicalMedical centerModelingMusMutateMyeloid CellsNatural ImmunityNucleotidesPathogenesisPathogenicityPhosphodiesterase IPhosphoric Monoester HydrolasesPlayPopulationPost Translational Modification AnalysisPost-Translational Protein ProcessingPropertyProteinsProteomicsRecombinantsRegulationResearchReverse TranscriptionRoleSamplingSubfamily lentivirinaeSystemTestingTetracyclinesTherapeuticUnited States National Institutes of HealthUniversitiesViral GenomeVirionVirusVirus Replicationbasebiobankcellular targetingclinical materialexperiencefightinggenetic regulatory proteinimmune activationin vitro Assayin vivoinducible gene expressioninfectious disease treatmentinorganic phosphateinsightmacrophagemonocytemutantnonhuman primatenucleasepathogenpreventpublic health relevancetransmission processtripolyphosphateubiquitin ligaseubiquitin-protein ligasevpr Gene Products
项目摘要
DESCRIPTION (provided by applicant): HIV-1 and other lentiviruses encode accessory proteins, each of which plays a role in facilitating virus replication and causing pathogenesis. Several of the accessory proteins exert their effect by counteracting antiviral cell proteins. This
project focuses on understanding how the two HIV-related accessory proteins, Vpr and Vpx, facilitate virus replication. These proteins are 50% similar in amino acid sequence, are packaged in the virion, localize to the nucleus and bind a specific E3 ubiquitin ligase. Vpx, which
is encoded in HIV-2 and SIVmac but not HIV-1, targets the cellular enzyme SAMHD1 for degradation. The target of Vpr has not yet been identified. The mechanism by which SAMHD1 inhibits viruses is not clear. It is a phosphohydrolase that when expressed in myeloid cells, removes the phosphates from the deoxynucleotide triphosphates, depleting the pool of intracellular dNTPs. SAMHD1 is also an exonuclease and which of these activities restricts virus replication is not clear. SAMHD1 does not block the replication of SIVmac or HIV-2 as these viruses encode Vpx. This project seeks to understand (i) the mechanism by which SAMHD1 restricts HIV-1; (ii) how Vpx binds and targets SAMHD1 for degradation; (iii) how Vpx is released from the virus following infection; (iv) how the enzymatic activity of the protein is regulated by post-translational modifications or by associating with regulatory proteins; (v) which
amino acid residues of Vpx and SAMHD1 allow the proteins to interact; (vi) how Vpx is imported into the nucleus and (vii) the role of SAMHD1 in the innate immune response to HIV-1 infection. Lastly, an inducible expression system for Vpr will be established to identify the targeted host factor. The findings will shed light on a new mechanism by which the innate immune system restricts HIV-1 and other human pathogens and how viruses have evolved to escape the restriction. Understanding this may provide strategies to therapeutically enhance the effectiveness of the innate immune response for the treatment of infectious diseases.
描述(由申请人提供):HIV-1和其他慢病毒编码辅助蛋白,每种蛋白质都在促进病毒复制和引起发病机理中起作用。几种辅助蛋白通过抵消抗病毒细胞蛋白来发挥其作用。这
项目着重于了解两种与HIV相关的辅助蛋白(VPR和VPX)如何促进病毒复制。这些蛋白质在氨基酸序列中的50%相似,在病毒粒子中包装,定位于细胞核并结合特定的E3泛素连接酶。 VPX,哪个
在HIV-2和SIVMAC中编码,而不是HIV-1,靶向细胞酶SAMHD1以降解。 VPR的目标尚未确定。 SAMHD1抑制病毒的机制尚不清楚。这是一种磷酸化水酶,当在髓样细胞中表达时,从脱氧核苷酸三磷酸盐中去除磷酸盐,从而耗尽细胞内DNTP的池。 SAMHD1也是一种核酸酶,其中哪些活动限制了病毒复制,尚不清楚。 SAMHD1不会阻止SIVMAC或HIV-2的复制,因为这些病毒编码VPX。该项目试图了解(i)SAMHD1限制HIV-1的机制; (ii)VPX如何结合和靶向SAMHD1进行降解; (iii)感染后如何从病毒中释放VPX; (iv)蛋白质的酶活性如何受翻译后修饰或与调节蛋白相关的调节; (v)哪个
VPX和SAMHD1的氨基酸残基允许蛋白质相互作用。 (vi)如何将VPX进口到核和(vii)SAMHD1在对HIV-1感染的先天免疫反应中的作用。最后,将建立一个可诱导的VPR表达系统,以识别目标宿主因子。这些发现将阐明一种新的机制,其先天免疫系统限制了HIV-1和其他人类病原体以及病毒如何发展以逃避限制。理解这可能会提供治疗策略,以增强先天免疫反应治疗传染病的有效性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.
- DOI:10.1186/1743-422x-11-108
- 发表时间:2014-06-09
- 期刊:
- 影响因子:4.8
- 作者:Hakata Y;Miyazawa M;Landau NR
- 通讯作者:Landau NR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nathaniel R. Landau其他文献
Nathaniel R. Landau的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nathaniel R. Landau', 18)}}的其他基金
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
APOBEC3G/CEM15 抑制慢病毒复制
- 批准号:
8679134 - 财政年份:2013
- 资助金额:
$ 42.38万 - 项目类别:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
APOBEC3G/CEM15 抑制慢病毒复制
- 批准号:
8056761 - 财政年份:2010
- 资助金额:
$ 42.38万 - 项目类别:
APOBEC3G/CEM15 Inhibition of Lentivirus Replication
APOBEC3G/CEM15 抑制慢病毒复制
- 批准号:
7926684 - 财政年份:2009
- 资助金额:
$ 42.38万 - 项目类别:
The Role of Vpr and Vpx in Lentivirus Replication
Vpr和Vpx在慢病毒复制中的作用
- 批准号:
8659871 - 财政年份:2007
- 资助金额:
$ 42.38万 - 项目类别:
相似国自然基金
基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
- 批准号:32271536
- 批准年份:2022
- 资助金额:54.00 万元
- 项目类别:面上项目
模板化共晶聚合合成高分子量序列聚氨基酸
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
模板化共晶聚合合成高分子量序列聚氨基酸
- 批准号:22201105
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于祖先序列重构的D-氨基酸解氨酶的新酶设计及分子进化
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
C-末端40个氨基酸插入序列促进细菌脂肪酸代谢调控因子FadR转录效率的机制研究
- 批准号:82003257
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
- 批准号:
10679532 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别:
Myocardial Physiology of Growth Differentiation Factor Signaling
生长分化因子信号传导的心肌生理学
- 批准号:
10711086 - 财政年份:2023
- 资助金额:
$ 42.38万 - 项目类别: